ERBB2 and breast cancer: The PI3K‐AKT signaling pathway was a key regulator of tumor angiogenesis of HER2‐low breast cancers, and the aberrant activation could lead to the formation of immature, spatially heterogeneous vasculature and uneven perfusion, so the imaging findings may thus serve as an indirect predictor [8].